Henry Schein (NASDAQ:HSIC) Issues FY 2025 Earnings Guidance

Henry Schein (NASDAQ:HSIC) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.800-4.940 for the period, compared to the consensus estimate of 4.970. The company issued revenue guidance of $12.4 billion-$13.2 billion, compared to the consensus revenue estimate of $13.2 billion. Henry Schein also updated its FY25 guidance to $4.80-4.94 EPS.

Analysts Set New Price Targets

Several research analysts recently commented on HSIC shares. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a research report on Wednesday. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective on the stock. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Finally, UBS Group cut their price objective on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Stock Performance

HSIC stock traded up $0.05 during trading hours on Thursday, hitting $72.60. 563,873 shares of the stock were exchanged, compared to its average volume of 1,653,050. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein has a 12 month low of $63.67 and a 12 month high of $82.49. The firm has a market capitalization of $9.05 billion, a P/E ratio of 29.88, a P/E/G ratio of 2.13 and a beta of 0.91. The company has a 50-day simple moving average of $74.28 and a two-hundred day simple moving average of $72.43.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the business posted $0.66 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, analysts forecast that Henry Schein will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.